About OpSens

Fiber optic sensors manufacturer offering solutions for interventional cardiology Fractional Flow Reserve FFR, Oil and Gas and industrial applications.

Board of Directors

President, Chief Executive Officer / Louis Laflamme, CPA

Louis Laflamme became President, Chief Executive Officer and Director of Opsens in January 2013. He had been Chief Financial Officer and Corporate Secretary of the Company from November 2005 to January 2013. His main tasks are to define and execute the Company’s strategy both toward shareholders and the financial community in operational administrative activities. From March 2005 to November 2005, he was Director, Finance and Administration for DEQ Systems Corp. (TSXV:DEQ), a company manufacturing and distributing electronic systems for tables gambling. From 2002 to 2005, Mr. Laflamme held various positions within the administration department including that of Vice President Finance at TGN biotech inc., a company specializing in research and development in biotechnology. From January 2002 to July 2002, Mr. Laflamme also served as Corporate Controller at St-Raymond Forest Products Ltd., a company involved in the manufacturing of wood veneer. From 1998 to 2001, he was Chief of Mission in the department certification consulting for Samson Bélair / Deloitte & Touche LLP. Mr. Laflamme is a member of Quebec\’s Order of Chartered Professional Accountants since 2001. He received a BA in Business Administration from Université Laval in 1998.

President Opsens Solutions / Gaétan Duplain

Gaétan Duplain has been President of Opsens Solutions since October 2006. His primary responsibilities are to oversee the energy sector’s research activities by orienting the main lines of commercial and intellectual property development, planning the work and implementing the Corporation’s action plan. In 1994, he co-founded FISO Technologies Inc., a company manufacturing fiber optic sensors, where acted as Vice-President from 1994 to 2003. With this company, Mr. Duplain acquired experience in high-tech business development and strategic planning. He obtained a Bachelor’s degree in Physical Engineering from Université Laval in 1985 and a Master’s degree in Optics and Laser from the same university in 1986.

Executive Chairman of the Board / Alan Milinazzo

Mr. Alan Milinazzo currently serves as the Americas’ Regional Managing Partner for the Healthcare and Life Science practice at Heidrick & Struggles, one of the foremost executive search and consulting firms globally, since June 2016.

Prior to joining Heidrick & Struggles, he was CEO of InspireMD, a pioneer in embolic prevention systems (EPS) for coronary and vascular applications, from June 2013 to May 2016.
He previously served as President and CEO of Orthofix International N.V., a $600 million publicly traded global orthopedic and spine company, and as General Manager of Medtronic, Inc.’s coronary and peripheral vascular businesses, where he was instrumental in the development and commercialization of several key products including the company’s first coronary drug-coated stent platform, Endeavor. Mr. Milinazzo also spent 12 years with Boston Scientific in multiple global sales and marketing leadership roles during a period of unprecedented top line growth in the cardiology franchise.

Mr. Milinazzo currently serves as the Executive chair of the Corporation. Prior directorships include Flexion Therapeutics where he served as Chair of the Compensation Committee(Nasdaq: FLXN acquired by Pacira). CasMed (Nasdaq CASM, acquired by Edwards Life Science), Nasdaq LDR Spine (Nasdaq LDRH acquired by Zimmer-Biomet), Medpace (acquired by PE sponsor Cinven), HET Systems (acquired by Covidien), LumenR (acquired by Boston Scientific), and The Musculoskeletal Transplant Foundation.

Mr. Milinazzo earned a bachelor’s degree, cum laude, from Boston College. While in college, he interned at the White House, the US House of Representatives, and the John F. Kennedy Library.

Director / Lori Chmura

Mrs. Lori Chmura is currently President and CEO of Soundbite, a privately held medical device company since September 2020. Prior to Soundbite, Mrs. Chmura led Dune Medical Devices, a privately held company in the women’s health space, as the CEO, from January 2016 exiting with a sale to Dilon Technologies in April 2020. Prior to Dune Medical, she has held roles in Senior leadership in several blue chip medical device companies such as J&J, Covidien, and Medtronic as well as with Datascope Cardiac Assist.

Mrs. Chmura began her career as a Critical Care Registered Nurse, working in critical care, trauma, and emergency medicine. These experiences established a strong foundation of expertise in the clinical implications of technology on patients and within the healthcare system. Mrs. Chmura is a champion of change management, a transformational leader, and passionate about delivering growth. She has led numerous Women’s leadership initiatives and currently serves on the ADVAMED Women’s Executive Network Board and is Past President-Elect of the Atlanta Chapter board for the Healthcare Businesswomen’s Association. She was the 2018 the SEMDA Women of the Year, and a finalist for the 2018 Healthcare Hero’s award for Healthcare Innovation.

She holds a BSN from Southern Connecticut State University, and is expecting an MBA from Duke University in Spring of 2024.

Director / Denis Harrington

Mr. Denis Harrington is the owner of Denis L. Harrington Consulting, LLC, a management and strategy consulting firm he established in December 2012 after nearly 30 years of successful leadership roles in the US Army and the Medical Device Industry.

Mr. Harrington presently serves as President and CEO of VentureMed Group, Inc, an early-commercial stage, medical device company focused on interventional vessel preparation catheter technologies. He is also an executive consultant and director for two additional medical device companies. He has previously served as CEO for BridgePoint Medical and NexGen Medical, successfully leading BridgePoint from its development stage through commercialization and to successful acquisition by Boston Scientific in October 2012. He came to BridgePoint Medical from Boston Scientific where he spent 18 years. His last role at BSC was as Senior VP of US Cardiology, Rhythm and Vascular Sales – managing over 1800 people and $3 billion in revenue.

Mr. Harrington is a graduate of the United States Military Academy at West Point.

Director / Jean Lavigueur, CPA

Mr. Jean Lavigueur is Chief Financial Officer of Coveo Solutions Inc. (TSX:CVO), a software as a service leader in the field of enterprise search engines since April 2006. Before Coveo Solutions Inc., he co-founded and served as Chief Financial Officer of Taleo Corporation (NASDAQ:TLEO), a software as a service provider of talent management solutions, from 1999 until 2005. Prior to Taleo Corporation, Mr. Lavigueur served as Chief Financial Officer of Baan Supply Chain Solutions (“BAAN”), a software provider of enterprise resource planning, from 1996 until 1999, and as Chief Financial Officer of Berclain Group Inc., a supply chain management solutions vendor acquired by BAAN, from 1991 until 1996. Prior to his employment with Berclain Group Inc. Mr. Lavigueur worked in the audit and tax divisions of Coopers & Lybrand (now PricewaterhouseCoopers LLP), a public accounting firm. He was a member of the board of directors and of the Audit Committee of Wanted Technologies Corporation (TSXV:WAN), a software as a service vendor that provided real-time market intelligence data for the recruitment market and was the Chairman of its Special Committee of Independent Directors when the corporation was sold and privatized in 2015. He was a member of the board of directors of iPerceptions Inc. (TSXV:IPE), a web-focused Voice of Customer analytics provider, and was Chairman of its Audit Committee and of its Special Committee of Independent Directors when the corporation was sold and privatized in 2012. Mr. Lavigueur was also a member of the board of directors of Cossette Inc. (TSX:KOS), one of the largest advertising and communications corporation in Canada, and was the Chairman of its Audit Committee and of its Special Committee of Independent Directors when the corporation was sold and privatized in 2009. He is also currently a member of the board of directors of Vention Inc., a manufacturing automation solution provider.

Mr. Lavigueur holds a Bachelor’s degree in Business Administration from Université Laval. He is a member of the Order of Chartered Professional Accountants of Québec.

Director / Pat Mackin

Mr. James Patrick Mackin is President, Chief Executive Officer and Chairman of Artivion, Inc. (NYSE:AORT) (“Artivion”) since September 2014, a leading cardiac and vascular surgery company focused on technologies to treat patients with aortic disease. Artivion markets and sells products in more than 80 countries worldwide.
Before joining Artivion, from August 2007 to July 2014, he was President of the Cardiac Rhythm Disease Management Division, the largest business at Medtronic, Inc. (NYSE:MDT) (“Medtronic”). From 2004 to 2006, also at Medtronic, he held the positions of Vice President, Vascular, Western Europe, where he launched the Corporation’s first drug-eluding stent called “Endeavour”, and from 2002 to 2004, he was Vice President and General Manager, of the Endovascular Business Unit. Prior to joining Medtronic, from 1996 to 2002, Mr. Mackin worked at Genzyme, Inc., serving as Senior Vice President and General Manager for the Cardiovascular Surgery Business Unit and as Director of Sales, Surgical Products division. From 1991 to 1996, Mr. Mackin held various sales and marketing roles at Deknatel/Snowden-Pencer, Inc. From 1988 to 1991 he was an officer in the U.S. Army.

Mr. Mackin received an MBA from the Kellogg School of Management at Northwestern University and is a graduate of the United States Military Academy at West Point.

Director / Denis Sirois

Mr. Denis M. Sirois is President and CEO of Telesystem Energy Ltd. since January 2017, a clean technology company which has developed the world’s most efficient and reliable river hydrokinetic system producing renewable, baseload power.

Mr. Sirois also acts as Vice President – Investments of Telesystem Ltd. since March 2006. Telesystem Ltd. is a technology-focused family office with long-term value creation and innovation as core principles. Telesystem Ltd. has invested over US$1.3B globally in venture opportunities of all stages and have concluded more than US$22 billion in transactions since inception.

Mr. Sirois has over 20 years of experience in corporate finance, mergers and acquisitions and private equity. Mr. Sirois currently sits on the board of directors of Telesystem Ltd (and affiliates), Telesystem Energy Ltd, Northstar Earth and Space Inc., journal Le Devoir Inc. and the Corporation.